Dawn Maze

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Venues

Leukemia

EJHaem

Blood advances

Bone marrow transplantation

University of Toronto

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Toronto

Canada

Assistant Professor :: Faculty of Medicine-Department of Medicine-Division of Hematology

Princess Margaret Cancer Centre

Canada

Clinician- Investigator :: Division of Medical Oncology and Hematology

Publications

James T England, Natasha Szuber, Shireen Sirhan, Tom Dunne, Sonia Cerquozzi, Madeleine Hill, Pierre J A Villeneuve, Jenny M Ho, Bekim Sadikovic, Pratibha Bhai, Nupur Krishnan, Sebastian Dowhanik, Chris Hillis, Jose-Mario Capo-Chichi, Hubert Tsui, Verna Cheung, Karine Gauthier, Hassan Sibai, Marta B Davidson, Aniket Bankar, Rouslan Kotchetkov, Vikas K Gupta, Dawn Maze
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study. Leukemia 38 (3) (2024)
Marta B Davidson, James A Kennedy, Jose-Mario Capo-Chichi, Yuliang Shi, Wei Xu, Verna Cheung, Andrea Arruda, Aniket Bankar, Guillaume Richard-Carpentier, Steven Chan, Dawn Maze, Mark D Minden, Aaron D Schimmer, Andre C Schuh, Hassan Sibai, Karen W L Yee, Anne Tierens, Auro Viswabandya, Vikas K Gupta
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood advances 8 (5) (2024)
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Karen W L Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard Carpentier, Steven M Chan, Aaron David Schimmer, Jad Sibai, Salman Alharbi, Josephine A Lucero, Swe Mar Linn, Mark D Minden, Andre C Schuh, Hassan Sibai
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol. Leukemia 38 (4) (2024)
Dawn Maze, Murat O Arcasoy, Ryan Henrie, Sonia Cerquozzi, Rammurti Kamble, Samer Al-Hadidi, Abdulraheem Yacoub, Anurag K Singh, Mahmoud Elsawy, Shireen Sirhan, Elliot Smith, Curtis Marcoux, Auro Viswabandya, Andrew Daly, Hassan Sibai, Caroline McNamara, Yuliang Shi, Wei Xu, Katherine Lajkosz, Lynda Foltz, Vikas K Gupta
Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study. Bone marrow transplantation (2024)
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Karen W L Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard Carpentier, Steven M Chan, Aaron David Schimmer, Jad Sibai, Salman Alharbi, Josephine A Lucero, Swe Mar Linn, Mark D Minden, Andre C Schuh, Hassan Sibai
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol. Leukemia (2024)
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Andre C Schuh, Karen Wl Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard-Carpentier, Steven M Chan, Jad Sibai, Aaron David Schimmer, Mark D Minden, Hassan Sibai
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Andre C Schuh, Karen Wl Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard-Carpentier, Steven M Chan, Jad Sibai, Aaron David Schimmer, Mark D Minden, Hassan Sibai
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
James T England, Natasha Szuber, Shireen Sirhan, Tom Dunne, Sonia Cerquozzi, Madeleine Hill, Pierre J A Villeneuve, Jenny M Ho, Bekim Sadikovic, Pratibha Bhai, Nupur Krishnan, Sebastian Dowhanik, Chris Hillis, Jose-Mario Capo-Chichi, Hubert Tsui, Verna Cheung, Karine Gauthier, Hassan Sibai, Marta B Davidson, Aniket Bankar, Rouslan Kotchetkov, Vikas K Gupta, Dawn Maze
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study. Leukemia 38 (3) (2024)
James T England, Natasha Szuber, Shireen Sirhan, Tom Dunne, Sonia Cerquozzi, Madeleine Hill, Pierre J A Villeneuve, Jenny M Ho, Bekim Sadikovic, Pratibha Bhai, Nupur Krishnan, Sebastian Dowhanik, Chris Hillis, Jose-Mario Capo-Chichi, Hubert Tsui, Verna Cheung, Karine Gauthier, Hassan Sibai, Marta B Davidson, Aniket Bankar, Rouslan Kotchetkov, Vikas K Gupta, Dawn Maze
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study. Leukemia 38 (3) (2024)
Marta B Davidson, James A Kennedy, Jose-Mario Capo-Chichi, Yuliang Shi, Wei Xu, Verna Cheung, Andrea Arruda, Aniket Bankar, Guillaume Richard-Carpentier, Steven Chan, Dawn Maze, Mark D Minden, Aaron D Schimmer, Andre C Schuh, Hassan Sibai, Karen W L Yee, Anne Tierens, Auro Viswabandya, Vikas K Gupta
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood advances 8 (5) (2024)
James T England, Natasha Szuber, Shireen Sirhan, Tom Dunne, Sonia Cerquozzi, Madeleine Hill, Pierre J A Villeneuve, Jenny M Ho, Bekim Sadikovic, Pratibha Bhai, Nupur Krishnan, Sebastian Dowhanik, Chris Hillis, Jose-Mario Capo-Chichi, Hubert Tsui, Verna Cheung, Karine Gauthier, Hassan Sibai, Marta B Davidson, Aniket Bankar, Rouslan Kotchetkov, Vikas K Gupta, Dawn Maze
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study. Leukemia (2024)
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Karen W L Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard Carpentier, Steven M Chan, Aaron David Schimmer, Jad Sibai, Salman Alharbi, Josephine A Lucero, Swe Mar Linn, Mark D Minden, Andre C Schuh, Hassan Sibai
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol. Leukemia 38 (4) (2024)
James T England, Natasha Szuber, Shireen Sirhan, Tom Dunne, Sonia Cerquozzi, Madeleine Hill, Pierre J A Villeneuve, Jenny M Ho, Bekim Sadikovic, Pratibha Bhai, Nupur Krishnan, Sebastian Dowhanik, Chris Hillis, Jose-Mario Capo-Chichi, Hubert Tsui, Verna Cheung, Karine Gauthier, Hassan Sibai, Marta B Davidson, Aniket Bankar, Rouslan Kotchetkov, Vikas K Gupta, Dawn Maze
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study. Leukemia 38 (3) (2024)
Marta B Davidson, James A Kennedy, Jose-Mario Capo-Chichi, Yuliang Shi, Wei Xu, Verna Cheung, Andrea Arruda, Aniket Bankar, Guillaume Richard-Carpentier, Steven M Chan, Dawn Maze, Mark D Minden, Aaron D Schimmer, Andre C Schuh, Hassan Sibai, Karen W L Yee, Anne Tierens, Auro Viswabandya, Vikas K Gupta
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood advances (2024)
James T England, Natasha Szuber, Shireen Sirhan, Tom Dunne, Sonia Cerquozzi, Madeleine Hill, Pierre J A Villeneuve, Jenny M Ho, Bekim Sadikovic, Pratibha Bhai, Nupur Krishnan, Sebastian Dowhanik, Chris Hillis, Jose-Mario Capo-Chichi, Hubert Tsui, Verna Cheung, Karine Gauthier, Hassan Sibai, Marta B Davidson, Aniket Bankar, Rouslan Kotchetkov, Vikas K Gupta, Dawn Maze
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study. Leukemia 38 (3) (2024)
Dawn Maze, Murat O Arcasoy, Ryan Henrie, Sonia Cerquozzi, Rammurti Kamble, Samer Al-Hadidi, Abdulraheem Yacoub, Anurag K Singh, Mahmoud Elsawy, Shireen Sirhan, Elliot Smith, Curtis Marcoux, Auro Viswabandya, Andrew Daly, Hassan Sibai, Caroline McNamara, Yuliang Shi, Wei Xu, Katherine Lajkosz, Lynda Foltz, Vikas K Gupta
Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study. Bone marrow transplantation (2024)
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas K Gupta, Dawn Maze, Karen W L Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard Carpentier, Steven M Chan, Aaron David Schimmer, Jad Sibai, Salman Alharbi, Josephine A Lucero, Swe Mar Linn, Mark D Minden, Andre C Schuh, Hassan Sibai
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol. Leukemia 38 (4) (2024)
Dawn Maze, Murat O Arcasoy, Ryan Henrie, Sonia Cerquozzi, Rammurti Kamble, Samer Al-Hadidi, Abdulraheem Yacoub, Anurag K Singh, Mahmoud Elsawy, Shireen Sirhan, Elliot Smith, Curtis Marcoux, Auro Viswabandya, Andrew Daly, Hassan Sibai, Caroline McNamara, Yuliang Shi, Wei Xu, Katherine Lajkosz, Lynda Foltz, Vikas K Gupta
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study. Bone marrow transplantation (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)
Ruiqi Chen, Atenafu G Eshetu, Jack Seki, Xing Liu, Steven Chan, Vikas K Gupta, Dawn Maze, Andre C Shuh, Mark D Minden, Karen Yee, Aaron D Schimmer, Hassan Sibai
Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L-ASP: A retrospective analysis with an ASP-based protocol in adult patients with acute lymphoblastic leukaemia. British journal of haematology (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)
Dawn Maze, Iyad Arusi, Vikas K Gupta, Atenafu G Eshetu, Ann Kinga Malinowski, Nadine Shehata
Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms. EJHaem 4 (1) (2022)
Verna Cheung, James T England, Dawn Maze, Hassan Sibai
Osteolytic lesion in polycythemia vera: First report and review of literature. EJHaem 3 (2) (2022)
Ibrahim Al Nabhani, Claire Andrews, Jad Sibai, Atenafu G Eshetu, Taylor Young, Steven M Chan, Vikas K Gupta, Dawn Maze, Aaron D Schimmer, Andre C Schuh, Karen Yee, Hassan Sibai
Safety of re-challenging adults with acute lymphoblastic leukemia with PEG-asparaginase-induced severe hypertriglyceridemia when treated with a pediatric-inspired regimen. EJHaem 4 (1) (2022)
Dawn Maze, Iyad Arusi, Vikas K Gupta, Atenafu G Eshetu, Ann Kinga Malinowski, Nadine Shehata
Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms. EJHaem 4 (1) (2022)
Adam C Smith, Dawn Maze, Daniel Xia, Jose-Mario Capo-Chichi, Ian King, Hassan Sibai
A t(6;14;9)(p22;q22;q34) three-way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia. American journal of hematology 97 (7) (2022)
James T England, Caroline J McNamara, James A Kennedy, Jose-Mario Capo-Chichi, Jingyue Huang, Andrea Arruda, Taylor Nye, Verna Cheung, Jaime O Claudio, Dawn Maze, Hassan Sibai, Anne Tierens, Hubert Tsui, Aniket Bankar, Wei Xu, Tracy L Stockley, Vikas K Gupta
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort. Leukemia 36 (6) (2022)
Ibrahim Al Nabhani, Claire Andrews, Jad Sibai, Atenafu G Eshetu, Taylor Young, Steven M Chan, Vikas K Gupta, Dawn Maze, Aaron D Schimmer, Andre C Schuh, Karen Yee, Hassan Sibai
Safety of re-challenging adults with acute lymphoblastic leukemia with PEG-asparaginase-induced severe hypertriglyceridemia when treated with a pediatric-inspired regimen. EJHaem 4 (1) (2022)
Dawn Maze, Mahmood Al-Abri, Khadija Farooq, Atenafu G Eshetu, Shannon Nixon, Lani Lieberman
Risk factors for intracranial hemorrhage in adults with acute leukemia. Transfusion 61 (12) (2021)
Tracy Murphy, Jinfeng Zou, Georgina S Daher-Reyes, Andrea Arruda, Vikas Gupta, Caroline J McNamara, Mark D Minden, Aaron D Schimmer, Hassan Sibai, Karen W L Yee, Mariam Korulla, Tracy L Stockley, Suzanne Kamel-Reid, Dawn Maze, Anne Tierens, Scott V Bratman, Andre C Schuh, Steven M Chan
Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML. Blood advances 3 (15) (2020)
Shannon Nixon, Lani Lieberman, Eshetu G Atenafu, Mary Doherty, Cindy Murray, Amanda Wolfe, Danielle Brandys, Suzanne Rowland, Benjamin Ym Kwan, Eugene Yu, Breanne Lechner, Dawn Maze
Clinical outcomes and transfusion management following intracranial hemorrhage in patients with acute leukemia. Transfusion 60 (2) (2019)

Dawn Maze.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dawn Maze